Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2005

01-04-2005

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

Authors: Elizabeth A. Platz, Michael N. Pollak, Michael F. Leitzmann, Meir J. Stampfer, Walter C. Willett, Edward Giovannucci

Published in: Cancer Causes & Control | Issue 3/2005

Login to get access
Metadata
Title
Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era
Authors
Elizabeth A. Platz
Michael N. Pollak
Michael F. Leitzmann
Meir J. Stampfer
Walter C. Willett
Edward Giovannucci
Publication date
01-04-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 3/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-004-3484-8

Other articles of this Issue 3/2005

Cancer Causes & Control 3/2005 Go to the issue

OriginalPaper

Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case–control study in Wayne County, Michigan

OriginalPaper

Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States)

OriginalPaper

Hereditary colorectal cancer syndromes

OriginalPaper

Are risk factors for breast cancer associated with follow-up procedures in diverse women with abnormal mammography?

OriginalPaper

Fertility patterns prior to testicular cancer diagnosis

OriginalPaper

The impact of reproductive factors on breast cancer risk - The feasibility of using Swedish population-based registers to account for the effect of confounding in cohort studies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits